USPTO Examiner SWANSON LEAH JENNINGS - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17126295SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESDecember 2020October 2022Allow2200YesNo
17247395INTRAVASCULAR CATHETER INSERTION DEVICEDecember 2020November 2023Allow3600YesNo
17114235MEDICAMENT DELIVERY DEVICEDecember 2020September 2024Allow4550YesNo
17114238MEDICAMENT DELIVERY DEVICEDecember 2020August 2023Allow3220YesNo
17114241MEDICAMENT DELIVERY DEVICEDecember 2020August 2023Allow3220YesNo
15734773AN ENTERAL FEEDING DEVICEDecember 2020August 2024Allow4420YesNo
17055905QUICK RELEASE CAPSULESNovember 2020April 2025Abandon5321NoNo
17096845SYNERGISTIC FEATURES AND FUNCTIONS RELATED TO OPERATION OF A MEDICATION DELIVERY SYSTEM AND A MEAL TRANSACTION APPLICATIONNovember 2020November 2024Allow4850YesNo
17090236AUTO-INJECTION DEVICENovember 2020September 2021Allow1030YesNo
17048260SYRINGEOctober 2020December 2023Abandon3810NoNo
17042144FAT SUCTION AND GRAFT SYRINGE HAVING NEGATIVE PRESSURE ADJUSTMENT MEANSSeptember 2020October 2022Allow2510YesNo
17032715GASKET PRESSING TOOL AND DRUG ADMINISTRATION TOOL USING THE SAMESeptember 2020March 2025Allow5421NoNo
17040431DEVICE FOR ADMINISTERING A FLUIDSeptember 2020June 2024Abandon4520NoNo
17022936Steerable Medical Device HandleSeptember 2020March 2025Allow5440YesNo
16993062CATHETER ADAPTERSAugust 2020May 2023Allow3330YesNo
16969691CONTROLLED DISPENSE SYRINGEAugust 2020April 2023Allow3220YesNo
16932135HYPODERMIC DEVICE WITH AN ARRAY OF HYPODERMIC NEEDLESJuly 2020January 2023Abandon3040YesYes
16929081CLOSED-LOOP GLUCOSE AND/OR INSULIN CONTROL SYSTEMJuly 2020April 2023Abandon3310NoNo
16910640DEVICES AND METHODS FOR DELIVERING A LYOPHILIZED MEDICAMENTJune 2020January 2024Allow4320YesNo
16905382STIMULATION OF CARTILAGE FORMATION USING REDUCED PRESSURE TREATMENTJune 2020September 2022Allow2710NoNo
16898905PRESSURE CONTROL IN PHACOEMULSIFICATION SYSTEMJune 2020September 2022Allow2710NoNo
16898529WEARABLE AUTOMATED MEDICATION DELIVERY SYSTEMJune 2020April 2023Allow3420NoNo
16771084INJECTION DEVICE WITH A REMOTE CONTROLJune 2020November 2022Allow2910YesNo
16892100INFUSION PUMP SYSTEM AND METHODSJune 2020January 2023Abandon3150YesNo
16764638MEDICAL DELIVERY DEVICE WITH AXIALLY EXPANDABLE DRIVE RIBBONMay 2020August 2023Allow3910YesNo
16862448Cartilage repair, preservation and growth by stimulation of bone-chondral interface and delivery system and methods thereforApril 2020December 2021Allow1920YesNo
16858686CONTAINER ADAPTER FOR REMOVABLY ATTACHABLE SYRINGEApril 2020May 2021Allow1330YesNo
16849111SAFETY SYRINGEApril 2020November 2021Allow1900NoNo
16841398OCCLUSION DETECTION DEVICES, SYSTEMS, AND METHODSApril 2020February 2023Allow3540YesNo
16652082TEMPER EVIDENT INJECTOR LOCK AND A LOCKING METHODMarch 2020May 2022Abandon2510NoNo
16800177MEDICAMENT DELIVERY DEVICEFebruary 2020February 2022Allow2310YesNo
16793948EXTENSION TUBE CLAMP PROVIDING POSITIVE DISPLACEMENTFebruary 2020January 2022Allow2310YesNo
16785400SYSTEMS AND METHODS FOR ESTABLISHING A NERVE BLOCKFebruary 2020November 2021Allow2110YesNo
16636168INJECTOR PREMATURE ACTIVATION BLOCKING MECHANISMFebruary 2020April 2022Allow2710YesNo
16774213INTERNAL BALLOON SHEATHJanuary 2020April 2022Allow2730YesNo
16629820MULTI-NEEDLE MODULE SUITABLE FOR SKIN PROCEDURE AT SLOPEJanuary 2020February 2022Abandon2610NoNo
16623290DUAL NEEDLE SYRINGE FOR PREVENTING INFECTIONDecember 2019March 2022Allow2720YesNo
16712333VASCULAR RE-ENTRY CATHETERDecember 2019November 2023Abandon4720YesNo
16619853Injector DevicesDecember 2019June 2022Abandon3010NoNo
16616267AUTO INJECTOR WITH HOLLOW PLUNGER RODNovember 2019March 2023Abandon4010NoNo
16615005DEVICE ACTIVATION IMPACT/SHOCK REDUCTIONNovember 2019September 2022Allow3420YesNo
16609921Integrating Electronics into the Stopper of a CartridgeOctober 2019June 2024Abandon5580YesNo
16607323AUTO-INJECTION DEVICEOctober 2019June 2021Abandon2010NoNo
16580464APPARATUS AND METHODS FOR BIOMIMETIC EXPRESSION OF BREAST MILKSeptember 2019September 2021Allow2420NoYes
16564668ENDOSCOPIC CANNULASeptember 2019November 2020Allow1430NoNo
16491680Systems and Methods for Steering GuidewiresSeptember 2019September 2023Allow4830YesNo
16562245MEDICAL CONNECTORSeptember 2019February 2023Allow4120YesNo
16557505VASCULAR ACCESS DEVICES WITH INTEGRATED SAFETY FEATURESAugust 2019August 2023Allow4831YesNo
16548490APPARATUS AND KITS FOR FLUID INFUSIONAugust 2019May 2022Allow3320YesNo
16538969Auto-InjectorAugust 2019September 2022Allow3740YesNo
16485122Breast Milk Expression Apparatus and SystemAugust 2019November 2021Allow2730YesNo
16530845ASPIRATION CATHETER SYSTEMS AND METHODS OF USEAugust 2019October 2021Allow2640YesNo
16476756MICRONEEDLE PATCH APPLYING DEVICEJuly 2019June 2023Abandon4740NoNo
16456502SYSTEM, APPARATUS AND METHOD EMPLOYED WITH ENTERAL SYSTEMSJune 2019April 2022Allow3440YesNo
16431610INFUSION PUMP SYSTEM AND METHOD WITH COMMON LINE AUTO FLUSHJune 2019September 2021Abandon2740NoNo
16425598SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESMay 2019August 2020Allow1500YesNo
16424069Medical Infusion HolderMay 2019April 2022Abandon3540YesNo
16418434APPARATUS AND PROCESS FOR PRODUCING CO2 ENRICHED MEDICAL FOAMMay 2019July 2021Allow2630YesNo
16414532ASPIRATION CATHETER SYSTEMS AND METHODS OF USEMay 2019October 2022Allow4110NoNo
16409460Medication Delivery DeviceMay 2019December 2022Allow4410YesNo
16401874Method for Producing a Tube System for Medical ApplicationsMay 2019January 2023Abandon4430NoNo
16399359DIALYSIS SYSTEM HAVING AN AUTOCONNECTION MECHANISMApril 2019April 2023Allow4730YesNo
16390436Catheter Assembly With Guidewire, Catheter and Puncture NeedleApril 2019January 2021Allow2110YesNo
16386503ACCESS DEVICE WITH GUIDEWIRE AND RELATED METHODSApril 2019June 2022Abandon3810NoNo
16378347DEVICE AND METHOD FOR INTRAOCULAR DRUG DELIVERYApril 2019July 2023Abandon5130NoYes
16336378PURGE DEVICE FOR A SYSTEM FOR ADMINISTERING MEDICAL TREATMENT FLUIDSMarch 2019May 2021Allow2610NoNo
16299562Pressurized-Gas-Driven Infusion Pump and Method of Operating Such an Infusion PumpMarch 2019December 2023Abandon5750YesNo
16331352SYSTEM FOR PERFORMING PHACOEMULSIFICATIONMarch 2019September 2022Abandon4240NoNo
16279438DEVICES, SYSTEMS, AND METHODS FOR REGULATING GLUCOSE LEVELS INCLUDING TREATING DIABETESFebruary 2019March 2024Abandon6080YesNo
16323776Tubular Structures with Variable SupportFebruary 2019October 2023Abandon5630YesYes
16258141AMBULATORY INFUSION DEVICEJanuary 2019January 2023Allow4840YesNo
16253539SYSTEM AND METHOD FOR SYRINGE ENGAGEMENT WITH INJECTORJanuary 2019August 2021Allow3120NoNo
16252980OPTIMIZING MEDICATION DOSAGE BASED ON ANALYTE SENSOR DATAJanuary 2019June 2022Allow4130YesNo
16246210METHOD AND DEVICE FOR INSERTING AT LEAST ONE MEDICAL COMPONENT WITHIN THE BODYJanuary 2019March 2024Abandon6080YesNo
16317018DRUG DELIVERY DEVICEJanuary 2019September 2021Allow3300YesNo
16316309DRUG DELIVERY DEVICE COMPRISING AN ADJUSTMENT MEMBERJanuary 2019May 2022Allow4020NoNo
16232852Cap Assembly for a Medicament Delivery DeviceDecember 2018March 2021Allow2610NoNo
16312844METHOD AND APPARATUS FOR EXTRACTING AND DELIVERY OF ENTITIESDecember 2018May 2022Allow4120YesNo
16312476DRUG DELIVERY DEVICEDecember 2018August 2021Allow3210YesNo
16225225MEDICAL CONNECTOR AND CONNECTING METHOD OF MEDICAL CONNECTORDecember 2018July 2021Allow3111NoNo
16308738TRIPLE CHAMBER WITH PREFILLED INJECTION DEVICEDecember 2018October 2021Abandon3420NoNo
16306127OUTER CAP OF LIQUID MEDICINE-INJECTING DEVICENovember 2018July 2022Abandon4320YesNo
16192756INTRAVASCULAR CATHETER INSERTION DEVICENovember 2018August 2020Allow2100YesNo
16188277Oral Mucosal Electroporation Device and Use ThereofNovember 2018September 2020Allow2210YesNo
16182179INJECTION DEVICE WITH DOSING CONTROL MEANSNovember 2018June 2021Allow3120YesNo
16160231Spacer Assembly for Drug Delivery DeviceOctober 2018February 2022Allow4021YesNo
16157002HUMIDIFICATION APPARATUS HAVING RFID TAG SENSOR AT PATIENT END OF GAS PATHWAYOctober 2018February 2022Allow4040YesNo
16089951DEVICE FOR INTRA MEDULLARY ANTIBIOTICS PERFUSIONSeptember 2018December 2022Abandon5020NoNo
16089750METHOD FOR MANUFACTURING MINUTE HOLLOW PROTRUDING TOOL, AND MINUTE HOLLOW PROTRUDING TOOLSeptember 2018March 2023Abandon5331YesNo
16141131Insulin Infusion SetSeptember 2018September 2020Abandon2410NoNo
16115804Dialysis Machine Support Assemblies and Related Systems and MethodsAugust 2018July 2020Allow2300NoNo
16114290VASCULAR ACCESS DEVICE AND METHODAugust 2018November 2019Allow1520YesNo
16111019SYSTEMS AND METHODS FOR THERAPY TITRATION IN HEART FAILUREAugust 2018August 2022Allow4820YesYes
16110776Yankauer Suction System and Related Methods with Clog Removal FunctionalityAugust 2018August 2021Abandon3620NoNo
16076348SKIN SURFACE INDWELLING DEVICE FOR GUIDING PUNCTURESAugust 2018June 2022Allow4630YesNo
16057115ELECTROMANIPULATION OF CELLS AND OTHER BIOLOGICAL TISSUES BY PULSEDELECTRIC FIELDS AT ELEVATED TEMPERATURESAugust 2018January 2020Allow1700YesNo
16054552NEEDLE AND CATHETER INSERTION DEVICEAugust 2018April 2025Allow6060YesYes
16046186MEDICAL ELONGATED BODYJuly 2018August 2021Allow3731YesNo
16045861ADHESIVE PHOTOTHERAPY METHOD, SYSTEM, AND DEVICES FOR ACNEJuly 2018October 2024Allow60121YesNo
16072875MICRONEEDLE DEVICEJuly 2018June 2021Abandon3420NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SWANSON, LEAH JENNINGS.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
6
Examiner Affirmed
5
(83.3%)
Examiner Reversed
1
(16.7%)
Reversal Percentile
29.7%
Lower than average

What This Means

With a 16.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
5
(20.0%)
Not Allowed After Appeal Filing
20
(80.0%)
Filing Benefit Percentile
27.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SWANSON, LEAH JENNINGS - Prosecution Strategy Guide

Executive Summary

Examiner SWANSON, LEAH JENNINGS works in Art Unit 3783 and has examined 255 patent applications in our dataset. With an allowance rate of 66.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner SWANSON, LEAH JENNINGS's allowance rate of 66.3% places them in the 28% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by SWANSON, LEAH JENNINGS receive 3.02 office actions before reaching final disposition. This places the examiner in the 84% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SWANSON, LEAH JENNINGS is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +34.3% benefit to allowance rate for applications examined by SWANSON, LEAH JENNINGS. This interview benefit is in the 81% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.9% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 21.8% of cases where such amendments are filed. This entry rate is in the 30% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 36.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 41.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 44.8% are granted (fully or in part). This grant rate is in the 36% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.